Norpace (Disopyramide)
Order Name
NORPACE
Test Number: 4003260
Revision Date 12/12/2022
Test Number: 4003260
Revision Date 12/12/2022
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Norpace (Disopyramide)
|
Immunoassay (IA) |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 1mL (0.3 mL) | Serum | Clot Activator (Red Top, No-Gel) | Room Temperature |
| Alternate 1 | 1mL (0.3 mL) | Plasma | EDTA (Lavender Top) | Room Temperature |
| Instructions | Specimen Type: Red-top tube, lavender-top (EDTA) tube OR green-top (heparin) tube. DO NOT USE A GEL-BARRIER TUBE. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant. Specimen Storage: Room Temperature Specimen Collection: Transfer separated serum or plasma to a plastic transport tube. Specimen Stability: Ambient: 14 days, Refrigerated : 14 days, Frozen: 14 days |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 2 - 3 days working day. |
| Clinical Use | Disopyramide is useful in treating patients with cardiac arrhythmias and tachcardia. Therapeutic drug monitoring is useful to optimize dose and avoid toxicity. |
| Performing Labcorp Test Code | 007864 |
| Notes | Labcorp Test Code: 007864 |
| CPT Code(s) | 80299 |
| Lab Section | Reference Lab |